Who is sponsoring NCT03710213?

NCT03710213 is sponsored by University of Pennsylvania.

What drugs are being tested in NCT03710213?

Interventions in NCT03710213: Text Message-based Intervention.

What condition does NCT03710213 study?

NCT03710213 studies Adherence, Patient, Colonoscopy, Text Messaging.

Is NCT03710213 still recruiting?

NCT03710213 is currently completed. Last updated 6 January 2020.

Last reviewed 2020-01-06 · How we verify

NCT03710213

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Automated Navigation to Improve Outpatient Colonoscopy Adherence

Completed NA Last updated 6 January 2020

What this trial tests

NA trial testing Text Message-based Intervention in Adherence, Patient in 752 participants. Completed in 18 September 2019.

Timeline

26 November 2018

Primary endpoint
18 September 2019

18 September 2019

Quick facts

Lead sponsor	University of Pennsylvania
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	health services research
Enrollment	752
Start date	26 November 2018
Primary completion	18 September 2019
Estimated completion	18 September 2019
Sites	1 location across United States

Drugs / interventions tested

Text Message-based Intervention

Conditions studied

Adherence, Patient — all drugs for Adherence, Patient →
Colonoscopy — all drugs for Colonoscopy →
Text Messaging — all drugs for Text Messaging →

Sponsor

University of Pennsylvania

Who can join

Adults 18 to 85, any sex, with Adherence, Patient or Colonoscopy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Outpatient colonoscopy adherence is negatively impacted by poor communication and challenges with bowel preparation. We plan to perform a randomized controlled trial at the Pennsylvania Presbyterian Medical Center to (1) provide text message-based educational and reminder messages to patients regarding a scheduled colonoscopy, and (2) evaluate the impact of the texting intervention on colonoscopy show rate and bowel preparation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of Text Messaging on Bowel Preparation and Appointment Attendance for Outpatient Colonoscopy: A Randomized Clinical Trial.
Mahmud N, Asch DA, Sung J, Reitz C, et al · · 2021 · cited 24× · PMID 33492374 · DOI 10.1001/jamanetworkopen.2020.34553

Verify or expand the search:

Other recruiting trials for Adherence, Patient

Currently open trials in the same condition.

NCT07261553 — Adherence to Home-Based Exercises in Musculoskeletal Disorders · recruiting
NCT05613010 — Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant · NA · recruiting
NCT05832008 — Increasing Adherence to Lung Cancer Screening · NA · active not recruiting
NCT05448560 — A Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship · NA · active not recruiting
NCT04298905 — Leveraging mHealth to Enable and Adapt CHW Strategies to Improve TB/HIV Patient Outcomes in SA · NA · active not recruiting

Other University of Pennsylvania trials

Trials by the same sponsor.

NCT06081153 — Mechanistic Clinical Trial of PCSK9 Inhibition for AAA · EARLY_PHASE1 · not yet recruiting
NCT07415772 — Effect of cTBS on Startle and TMS-evoked BOLD · NA · not yet recruiting
NCT07489430 — DaxibotulinumtoxinA for Blepharospasm · Phase 2 · not yet recruiting
NCT07463131 — Negative Income Tax Trial · NA · not yet recruiting
NCT06645769 — Na-Phenylbutyrate VAscular Trial · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03710213 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Pennsylvania
Last refreshed: 6 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03710213.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing